CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Outcome for Financial Results For The Quarter And Half-Year Ended September 30, 2024

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Mid-range Performer

2008.6000 20.50 (1.03%)

NSE Aug 04, 2025 15:31 PM

38.33% Gain from 52W Low

Volume: 35,376

Caplin Point Laboratories Ltd.

07 Nov 2024

2008.60

1.03%

Board Meeting

CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Outcome for Financial Results For The Quarter …

BSE India

Financial Results for the quarter and half-year ended September 30, 2024 is enclosed

More from Caplin Point Laboratories Ltd.

Recommended

Market closes higher, Marico's revenue grows 23.3% YoY to Rs 3,259 crore in Q1

Trendlyne Marketwatch | 04 Aug 2025, 03:58PM

IPO calendar fills up: 12 new issues, and 12 listings this week

| 04 Aug 2025, 03:44PM

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets